Status:

RECRUITING

Identification of Hepatic Fibrosis Using 4D-MRI

Lead Sponsor:

University Hospital, Basel, Switzerland

Conditions:

Liver Diseases

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

To date, no specific treatment options exist for liver diseases, and there is a large global effort to find drugs that will halt liver disease progression in these patients.Liver fibrosis staging is e...

Detailed Description

Chronic liver diseases represent a rising global health threat. A prolonged inflammatory state leads to progressive fibrosis that can result in liver cirrhosis associated with serious complications in...

Eligibility Criteria

Inclusion

  • age ≥ 18 years
  • (a) Patients with histologically confirmed chronic liver disease, including NAFLD, ALD, viral hepatitis B and C, genetic (e.g. Wilson disease, hemochromatosis) or autoimmune liver disease
  • (b) Patients with acute liver inflammation or cardiac blood congestion to the liver (as assessed by laboratory values, imaging findings and clinical history)
  • ability to understand and consent to participate in this study

Exclusion

  • Medical implant like cardiac pacemaker, pump, hip prosthesis
  • Metallic objects in the body (e.g. splinters after an accident)
  • Persons who have undergone brain or cardiac surgery
  • Claustrophobia
  • Body Weight \>140kg or as provided by the MR manufacturer
  • Pregnant and lactating women
  • (a) Active hepatocellular carcinoma (HCC) (remark: patients with a history of HCC and curative treatment can be included)
  • (a) CHILD C cirrhosis
  • (a) and (b) Patients with overt ascites (except if they respond to diuretic treatment and the ascites resolves)
  • (c) Metabolic syndrome, BMI \>30 kg/m2
  • (c) Acute or chronic liver disease
  • Patients not willing or able to give a written informed consent

Key Trial Info

Start Date :

August 1 2021

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 31 2026

Estimated Enrollment :

200 Patients enrolled

Trial Details

Trial ID

NCT05385237

Start Date

August 1 2021

End Date

December 31 2026

Last Update

March 18 2025

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Kantonsspital Baselland (KSL)

Liestal, Basel-Landschaft, Switzerland, 4410

2

University Hospital Basel

Basel, Canton of Basel-City, Switzerland, 4052